529 related articles for article (PubMed ID: 16237477)
1. Pharmacokinetics of cannabinoids.
McGilveray IJ
Pain Res Manag; 2005; 10 Suppl A():15A-22A. PubMed ID: 16237477
[TBL] [Abstract][Full Text] [Related]
2. [Delta-9-tetrahydrocannabinol pharmacokinetics].
Goullé JP; Saussereau E; Lacroix C
Ann Pharm Fr; 2008 Aug; 66(4):232-44. PubMed ID: 18847571
[TBL] [Abstract][Full Text] [Related]
3. [Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis].
Goullé JP; Guerbet M
Bull Acad Natl Med; 2014 Mar; 198(3):541-56; discussion 556-7. PubMed ID: 26427296
[TBL] [Abstract][Full Text] [Related]
4. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
[TBL] [Abstract][Full Text] [Related]
5. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
[TBL] [Abstract][Full Text] [Related]
7. Marijuana poisoning.
Fitzgerald KT; Bronstein AC; Newquist KL
Top Companion Anim Med; 2013 Feb; 28(1):8-12. PubMed ID: 23796481
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of Action and Pharmacokinetics of Cannabis.
Chayasirisobhon S
Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
[TBL] [Abstract][Full Text] [Related]
9. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
[TBL] [Abstract][Full Text] [Related]
10. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: a focus on pharmacokinetic variability and pharmacodynamics.
Badowski ME
Cancer Chemother Pharmacol; 2017 Sep; 80(3):441-449. PubMed ID: 28780725
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid.
Kauert GF; Ramaekers JG; Schneider E; Moeller MR; Toennes SW
J Anal Toxicol; 2007 Jun; 31(5):288-93. PubMed ID: 17579974
[TBL] [Abstract][Full Text] [Related]
12. Psychoactive constituents of cannabis and their clinical implications: a systematic review.
Casajuana Köguel C; López-Pelayo H; Balcells-Olivero MM; Colom J; Gual A
Adicciones; 2018 Apr; 30(2):140-151. PubMed ID: 28492950
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic Profile of Oral Cannabis in Humans: Blood and Oral Fluid Disposition and Relation to Pharmacodynamic Outcomes.
Vandrey R; Herrmann ES; Mitchell JM; Bigelow GE; Flegel R; LoDico C; Cone EJ
J Anal Toxicol; 2017 Mar; 41(2):83-99. PubMed ID: 28158482
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
[TBL] [Abstract][Full Text] [Related]
15. [Some practice-relevant aspects of the pharmacokinetics of THC].
Grotenhermen F
Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():37-9. PubMed ID: 10575287
[TBL] [Abstract][Full Text] [Related]
16. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.
Huestis MA
Handb Exp Pharmacol; 2005; (168):657-90. PubMed ID: 16596792
[TBL] [Abstract][Full Text] [Related]
18. Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinol.
Johansson E; Gillespie HK; Halldin MM
J Anal Toxicol; 1990; 14(3):176-80. PubMed ID: 2165199
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette.
Marsot A; Audebert C; Attolini L; Lacarelle B; Micallef J; Blin O
J Pharm Pharm Sci; 2016; 19(3):411-422. PubMed ID: 27806250
[TBL] [Abstract][Full Text] [Related]
20. [Time profile of serum THC levels in occasional and chronic marihuana smokers after acute drog use - implication for drivind motor vehicles].
Balíková M; Hložek T; Páleníček T; Tylš F; Viktorinová M; Melicher T; Androvičová R; Tomíček P; Roman M; Horáček J
Soud Lek; 2014; 59(1):2-6. PubMed ID: 24625019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
